About

Company Profile

Company Name Oncolys BioPharma Inc.
Established March 18, 2004
Capital fund ¥6,402 Million (December 31, 2018)
President & CEO Yasuo Urata
Business Summary Research, development, manufacturing, sale, and import and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents
Corporate headquarters 4-1-28 Toranomon, Minato-ku, Tokyo 105-0001 Japan (MAP)
Phone:+81-3-5472-1578
FAX:+81-3-5472-1488
Branch office and Lab Kobe Clinical Laboratory Center (MAP)
«Office»
HI-DEC 2F
6-7-4 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo 650-0047 Japan
Phone:+81-78-303-1380
Fax:+81-78-303-1381

«Assay Laboratory»
HI-DEC 3F
6-7-4 Minatojima Minamimachi, Chuo-ku, Kobe-shi, Hyogo 650-0047 Japan
US office 1 Bridge Plaza 2nd floor, Fort Lee, New Jersey, 07024 USA (MAP)
President:Yas(Yasunari) Kashihara

Company Profile (PDF)



Summary of Stock Information



Listing Tokyo Stock Exchange Mothers
Date of Listing December 6, 2013
Code 4588
Company Name Oncolys BioPharma Inc.
Number of shares outstanding 9,225,300 (as of June 2016)
Stock transaction unit 100 shares
Number of shareholders 8,752 (as of June 2016)
Fiscal Year January 1 to December 31
General Meeting of Shareholders Within 3 months of the relevant fiscal year end
Transfer agent Sumitomo Mitsui Trust Bank, Limited
Name of major shareholders Number of shares owned (shares) Ownership (%)
ASTELLAS PHARMA INC 727,200 7.88
WONIK CUBE CORP 712,900 7.73
YASUO URATA 320,700 3.48
DAIWA SECURITIES 248,700 2.7
NVCC NO.6 INVESTMENT LIMITED PARTNERSHIP 211,000 2.29
MATSUI SECURITIES 146,400 1.59
JAPAN SECURITIES FINANCE 144,900 1.57
BNY GCM CLIENT ACCOUNT JPRD AC ISG 137,010 1.49
INDIVIDUAL 120,100 1.3
MIZUHO SECURITIES ASIA LIMITED-CLIENT A/C 69250601 101,300 1.1